WHO Model Lists of Essential Medicines: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 29: | Line 29: | ||
*[[Formoterol]] | *[[Formoterol]] | ||
*[[Gefitinib]] | *[[Gefitinib]] | ||
*[[Imatinib]] | *[[Ibrutinib]] | ||
*[[Imatinib]] | |||
*[[Lidocaine]] | *[[Lidocaine]] | ||
*[[Methotrexate]] | *[[Methotrexate]] | ||
*[[Nilotinib]] | |||
*[[Pembrolizumab]] | *[[Pembrolizumab]] | ||
*[[Perindopril]] | *[[Perindopril]] | ||
Revision as of 13:17, 9 January 2024
WHO Model Lists of Essential Medicines:
- Abiraterone acetate
- Acetazolamide
- Acetylsalicylic Acid (Aspirin)
- Aciclovir
- Afatinib
- Amiodarone
- Amlodipine
- Apixaban
- Aprepitant
- Aripiprazole
- Asparaginase
- Atazanavir + ritonavir
- Atorvastatin
- Atorvastatin + perindopril + amlodipine
- Atropine
- Azithromycin
- Bedaquiline
- Bicalutamide
- Budesonide
- Budesonide + formoterol
- Clarithromycin
- Ciprofloxacin
- Cisplatin
- Dasatinib
- Erlotinib
- Ethambutol
- Formoterol
- Gefitinib
- Ibrutinib
- Imatinib
- Lidocaine
- Methotrexate
- Nilotinib
- Pembrolizumab
- Perindopril
- Pyrazinamide
- Ramipril
- Ribavirin
- Rituximab
- Tamoxifen
- Tiotropium bromide
- Trastuzumab
